Changing epidemiology of HCV infection in patient with oral lichen planus in north-west Italy. by Arduino, Paolo G et al.
Changing epidemiology of HCV infection in patient with oral lichen planus in 
North-West Italy. 
 
Paolo G. Arduino, Mario Carbone, Davide Conrotto, Alessio Gambino, Marco 
Cabras, Dora Karimi, Roberto Broccoletti. 
 
Department of Surgical Sciences, Oral Medicine Section, CIR-Dental School, 
University of Turin, Turin, Italy   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Short title: HCV infection in OLP. 
Computer system: Mac OS X, Version 10.14.3; Word-processor: Microsoft Word for 
Mac, Version 16.16.8 
Corresponding author: 
Dr. Paolo G. Arduino  
Department of Surgical Sciences; CIR - Dental School.   
School of Medicine, University of Turin.         
Oral Medicine Unit, Via Nizza 230, I-10126 Turin (Italy).  
Telephone:  + 390116631522; Fax: +39011618639. 
E-mail: paologiacomo.arduino@unito.it 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Key words: HCV prevalence; oral lichen planus. 
Dear editor, 
oral lichen planus (OLP) is a chronic inflammatory condition, affecting roughly 
1.5-2% of the total population, women almost more than twice as men; 
patients of all ages could be interested, more frequently in the fifth to sixth 
decades of life (Arduino, 2017).  
In the past 20 years, several studies have investigated the possible 
association of hepatitis C (HCV) infection and OLP in different countries, 
producing conflicting results (Lodi et al, 2010). A recent meta-analysis 
examined the prevalence of anti-HCV antibodies in the serum of cases and 
controls from 2005 to 2015 (Alaizari et al, 2016): authors reported a summary 
estimate OR for all studies of 6.07 (95% CI: 2.73-13.48), showing a 
statistically significant difference in the proportion of HCV seropositivity 
among OLP patients. 
During the 1990s, data collected in our unit described a prevalence 
of HCV antibodies in OLP patients (27.1%) as significantly higher than in 
control cases (4.3%) (Carrozzo et al, 1996); those data tended to reflect the 
strong existing association between lichen planus and chronic hepatic disease 
reported mainly in Southern Europe and in patients with erosive lesions 
(Gandolfo and Carrozzo, 2002). 
Very recently we published a prospective analysis, conducted on a 
comprehensive sample collected from a Caucasian population resident in 
Turin, North-west Italy, (Arduino et al, 2017); the case group consisted of 307 
OLP patients (histologically and clinically confirmed), all tested for HCV 
antibodies, between January 2015 and May 2017. Finally, eight (2.6%) 
subjects were found to have a positive HCV status, of whom 5 were female, 
with an average age of 60 (SD=12); the proportion of aware subjects was of  
87.5%, with only 1 patient unconscious of his status. This report is wholly 
different if compared with the previous obtained in the 1990s. 
In general, studies performed during the 1990s in Italy showed a high 
prevalence of HCV infection in the over-all population, with a peak in the 
oldest cohorts, but an unswerving decrease in this prevalence has been 
reported in European countries in the last decade, indicating that the 
epidemiology of hepatitis C has distinctly changed (Esteban et al, 2008). A 
very recent survey was run in five Italian metropolitan areas (one of which 
was Turin), from November 2014 to December 2015, reported an overall 
prevalence of 2.3% of anti-HCV positive patients, with a peak prevalence 
(7.0%) observed in people born in the years 1935-1944 (Andriulli et al, 2018). 
As discussed by Authors, an argued issue is whether general screening 
programs might lead to a better control of HCV, but data from their paper did 
not appear to support the need for it. 
Until now we regularly used to screen all new OLP confirmed patients for HCV 
antibodies, but probably this need should be revised bearing in mind latest 
epidemiological data, especially for younger patients. 
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